Lineage Cell Therapeutics, Inc. (LCTX)
1.33
0.00 (0.00%)
USD |
NYAM |
May 29, 16:00
1.34
+0.01
(+0.75%)
After-Hours: 20:00
Lineage Cell Therapeutics EPS Diluted (Quarterly) : -0.0273 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Curis, Inc. | -1.250 |
| Halozyme Therapeutics, Inc. | 1.221 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.789M |
| Revenue (Quarterly) | 1.725M |
| Total Expenses (Quarterly) | 6.537M |
| Enterprise Value | 279.40M |
| Gross Profit Margin (Quarterly) | 89.10% |
| Profit Margin (Quarterly) | -277.6% |
| Earnings Yield | -21.60% |
| Normalized Earnings Yield | -9.887 |